Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Revealing the Hidden Impact: Family Spillover E...
By
Thanusha Pillay
July 29, 2024
Introduction Cost-utility analysis (CUA) is increasingly used in healthcare decision-making for funding, reimbursement, and pricing of new interventions. Health Technology Assessment (HTA) agenci...
Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...
Challenges and Opportunities in Educating the Public About Childhood Arthriti...
Access to Essential Medicines for Rheumatic Diseases in Children
Paediatric Rheumatology Care in Africa: Hope and Resilience
Cost-Effectiveness of Skin Cancer Prevention Strategies
Forecasting Innovations in Cutaneous Malignant Melanoma Treatment in Sweden
Enhancing Skin Cancer Prevention in a Primary Care Setting
Addressing Valvular Heart Disease in Saudi Arabia
Best Practices for Preventing Statistical Pitfalls in Observational Research
Innovative Funding Models for Non-Communicable Diseases
« Previous
1
…
15
16
17
18
19
…
25
Next »